Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": The CASA randomized trial

被引：41

作者：

Crivellari, Diana ^{[1
]}

Gray, Kathryn P. ^{[2
,3
]}

Dellapasqua, Silvia ^{[4
]}

Puglisi, Fabio ^{[5
]}

Ribi, Karin ^{[6
]}

Price, Karen N. ^{[7
,8
]}

Lang, Istvan ^{[9
]}

Gianni, Lorenzo ^{[10
,11
]}

Spazzapan, Simon ^{[1
]}

Pinotti, Graziella ^{[12
,13
]}

Luethi, Jean-Marc ^{[14
]}

Gelber, Richard D. ^{[2
,3
,15
]}

Regan, Meredith M. ^{[2
,15
]}

Colleoni, Marco ^{[4
]}

Castiglione-Gertsch, Monica ^{[16
]}

Maibach, Rudolf ^{[8
,17
]}

Rabaglio, Manuela ^{[17
,18
]}

Coates, Alan S. ^{[19
,20
]}

Goldhirsch, Aron ^{[21
]}

机构：

[1] Ctr Riferimento Oncol, I-33081 Aviano, Italy

[2] Dana Farber Canc Inst, Dept Biostat & Computat Biol, IBCSG, Ctr Stat, Boston, MA 02115 USA

[3] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA

[4] European Inst Oncol, Dept Med, Res Unit Med Senol, Milan, Italy

[5] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy

[6] Int Breast Canc Study Grp, Coordinating Ctr, Qual Life Off, Bern, Switzerland

[7] Int Breast Canc Study Grp, Ctr Stat, Boston, MA USA

[8] Frontier Sci & Technol Res Fdn Inc, Boston, MA USA

[9] Natl Inst Oncol, Budapest, Hungary

[10] Osped Infermi Rimini, Dept Oncol, Rimini, Italy

[11] Ist Sci Romagnolo Studio & Cura Tumori, Rimini, Italy

[12] Osped Circolo Varese, Varese, Italy

[13] Fdn Macchi, Varese, Italy

[14] Spital SIS AG, Thun, Switzerland

[15] Harvard Univ, Sch Med, Boston, MA USA

[16] Univ Geneva, Dept Med Hop, Unite Oncogynecol Med, Geneva, Switzerland

[17] Int Breast Canc Study Grp, Coordinating Ctr, Bern, Switzerland

[18] Univ Bern, Inselspital, Dept Med Oncol, CH-3010 Bern, Switzerland

[19] Int Breast Canc Study Grp, Sydney, NSW, Australia

[20] Univ Sydney, Sydney, NSW 2006, Australia

[21] European Inst Oncol, Dept Med, Milan, Italy

来源：

BREAST | 2013年 / 22卷 / 02期

关键词：

Adjuvant treatment; Endocrine nonresponsive; Chemotherapy; Pegylated liposomal doxorubicin; Elderly; Breast cancer; QUALITY-OF-LIFE; ELDERLY-PATIENTS PTS; INTERNATIONAL SOCIETY; CAPECITABINE X; IBANDRONATE I; MINI-COG; PHARMACOKINETICS; CYCLOPHOSPHAMIDE; RECOMMENDATIONS; METHOTREXATE;

D O I：

10.1016/j.breast.2013.01.015

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

There is no optimal treatment for breast cancers lacking estrogen (ER) and progesterone (PgR) receptors in elderly women with co-morbidities that prevent use of "standard chemotherapy regimens" such as AC or CMF. The CASA trial studied pegylated liposomal doxorubicin (PLD) and low dose, metronomic cyclophosphamide methotrexate (CM) for older (>65), vulnerable women with operable, ER and PgR-negative breast cancer. After two years the trial closed early, due to slow and inadequate accrual, with 77 patients (38:PLD, 36:CM, 3:nil). Sixty-eight percent completed PLD; 83% completed CM (both 16 weeks). Patients on PLD reported worse quality of life, cognitive and physical functioning than non-PLD regimens (primarily CM). At a median follow-up of 42 months, 81% of randomized patients remained free of any breast cancer recurrence. Based on our limited experience, PLD and CM may be reasonable options for further study for elderly vulnerable patients with endocrine nonresponsive breast cancer. (C) 2013 Elsevier Ltd. All rights reserved.

引用

页码：130 / 137

页数：8

共 50 条

[41] Active symptom monitoring for premenopausal women with breast cancer initiating adjuvant endocrine therapy: Protocol for the SWOG S2010 randomized controlled efficacy trial [J].

Henry, N. L. ;

Unger, J. M. ;

Vaidya, R. ;

Darke, A. K. ;

Skaar, T. C. ;

Fisch, M. J. ;

Hershman, D. L. .

CONTEMPORARY CLINICAL TRIALS, 2024, 147

[42] A planned, prospective comparison of short-term quality of life outcomes among older patients with breast cancer treated with standard chemotherapy in a randomized clinical trial vs. an observational study: CALGB #49907 and #369901 [J].

Mandelblatt, Jeanne S. ;

Makgoeng, Solomon B. ;

Luta, Gheorghe ;

Hurria, Arti ;

Kimmick, Gretchen ;

Isaacs, Claudine ;

Tallarico, Michelle ;

Barry, William T. ;

Pitcher, Brandy ;

Winer, Eric P. ;

Hudis, Clifford ;

Cohen, Harvey J. ;

Muss, Hyman B. .

JOURNAL OF GERIATRIC ONCOLOGY, 2013, 4 (04) :353-361

[43] A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada-Clinical Trials Group Trial, MA.12) [J].

Bramwell, V. H. C. ;

Pritchard, K. I. ;

Tu, D. ;

Tonkin, K. ;

Vachhrajani, H. ;

Vandenberg, T. A. ;

Robert, J. ;

Arnold, A. ;

O'Reilly, S. E. ;

Graham, B. ;

Shepherd, L. .

ANNALS OF ONCOLOGY, 2010, 21 (02) :283-290

[44] A phase II randomized clinical trial of the effect of metformin versus placebo on progression-free survival in women with metastatic breast cancer receiving standard chemotherapy [J].

Pimentel, Isabel ;

Lohmann, Ana Elisa ;

Ennis, Marguerite ;

Dowling, Ryan J. O. ;

Cescon, David ;

Elser, C. ;

Potvin, K. R. ;

Haq, R. ;

Hamm, C. ;

Chang, Martin C. ;

Stambolic, Vuk ;

Goodwin, Pamela J. .

BREAST, 2019, 48 :17-23

[45] Photobiomodulation therapy prevents dysgeusia chemotherapy induced in breast cancer women treated with doxorubicin plus cyclophosphamide: a triple-blinded, randomized, placebo-controlled clinical trial [J].

Nobrega Malta, Cassia Emanuella ;

Matos Carlos, Anna Clara Aragao ;

Maciel de Alencar, Manuele Carine ;

Fernandes Alves e Silva, Eveline ;

Caitano Nogueira, Victor Bruno ;

Nunes Alves, Ana Paula Negreiros ;

Chaves, Fabio Figueiredo ;

Bastos de Moura, Jose Fernando ;

de Barros Silva, Paulo Goberlanio .

SUPPORTIVE CARE IN CANCER, 2022, 30 (03) :2569-2580

[46] Photobiomodulation therapy prevents dysgeusia chemotherapy induced in breast cancer women treated with doxorubicin plus cyclophosphamide: a triple-blinded, randomized, placebo-controlled clinical trial [J].

Cássia Emanuella Nóbrega Malta ;

Anna Clara Aragão Matos Carlos ;

Manuele Carine Maciel de Alencar ;

Eveline Fernandes Alves e Silva ;

Victor Bruno Caitano Nogueira ;

Ana Paula Negreiros Nunes Alves ;

Fábio Figueiredo Chaves ;

José Fernando Bastos de Moura ;

Paulo Goberlânio de Barros Silva .

Supportive Care in Cancer, 2022, 30 :2569-2580

[47] Low-dose pegylated recombinant human granulocyte-colony stimulating factor as hematopoietic support for adjuvant chemotherapy in Chinese patients with breast cancer: An open-label, randomized, non-inferiority trial [J].

Yang, Sheng ;

Chen, Shan-shan ;

Zhang, Chang-gong ;

Zhou, Ying-lei ;

Xiu, Meng ;

Zhang, Pin .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (10) :2621-2629

[48] Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9 [J].

Abraham, Jame ;

Robidoux, Andr ;

Tan, Antoinette R. ;

Limentani, Steven ;

Sturtz, Keren ;

Shalaby, Ibrahim ;

Alcorn, Hope ;

Buyse, Marc E. ;

Wolmark, Norman ;

Jacobs, Samuel A. .

BREAST CANCER RESEARCH AND TREATMENT, 2015, 152 (02) :399-405

[49] Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9 [J].

Jame Abraham ;

André Robidoux ;

Antoinette R. Tan ;

Steven Limentani ;

Keren Sturtz ;

Ibrahim Shalaby ;

Hope Alcorn ;

Marc E. Buyse ;

Norman Wolmark ;

Samuel A. Jacobs .

Breast Cancer Research and Treatment, 2015, 152 :399-405

[50] The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progress [J].

Kim, Hyun-Ah ;

Ahn, Sei Hyun ;

Nam, Seok Jin ;

Park, Seho ;

Ro, Jungsil ;

Im, Seock-Ah ;

Jung, Yong Sik ;

Yoon, Jung Han ;

Hur, Min Hee ;

Choi, Yoon Ji ;

Lee, Soo-Jung ;

Jeong, Joon ;

Cho, Se-Heon ;

Kim, Sung Yong ;

Lee, Min Hyuk ;

Kim, Lee Su ;

Moon, Byung-In ;

Kim, Tae Hyun ;

Park, Chanheun ;

Kim, Sei Joong ;

Jung, Sung Hoo ;

Park, Heungkyu ;

Gwak, Geum Hee ;

Kang, Sun Hee ;

Kim, Jong Gin ;

Kim, Jeryong ;

Choi, Su Yun ;

Lim, Cheol-Wan ;

Kim, Doyil ;

Yoo, Youngbum ;

Song, Young-Jin ;

Kang, Yoon-Jung ;

Jung, Sang Seol ;

Shin, Hyuk Jai ;

Lee, Kwan Ju ;

Han, Se-Hwan ;

Lee, Eun Sook ;

Han, Wonshik ;

Kim, Hee-Jung ;

Noh, Woo Chul .

BMC CANCER, 2016, 16

← 1 2 3 4 5 →